NFE2L2 and metabolic dysfunction-associated steatohepatitis: By contrast, loss of Nrf2 or deletion of Nrf2 has been found to cause benign steatosis to develop into NASH and contribute to exacerbation of disease status (Chowdhry et al., 2010; Wang et al., 2013).